Jason Duncan

Jason Duncan

Chief Legal OfficeratNeumora Therapeutics· In the 2023 proxy

Pay in FY2023

Jason Duncan was paid $4.1M in FY2023 (Dec).

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Neumora Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Neumora TherapeuticsPublic company · 3 yr
    • Chief Legal Officer2023 – Present · 3 yrStock in role -98%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?